Effect of intensive compared with moderate lipid-lowering therapy on progression of coronary atherosclerosis. a randomized controlled trial

The Effect of Pravastatin on Coronary Events after Myocardial Infarction in Patients with Average Cholesterol Levels

Frank M. Sacks, Marc A. Pfeffer, Lemuel A. Moyé et al. · New England Journal of Medicine · 1996 · 7.5K citations · Full text

Medicine, Pharmacology, Pharmacotherapy +16

Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial—Lipid Lowering Arm (ASCOT-LLA): a multicentre randomised controlled trial

Peter Sever, Björn Dahlöf, Neil R Poulter et al. · The Lancet · 2003 · 3.8K citations

Medicine, Cardiology, Pharmacotherapy +14

Simvastatin and Niacin, Antioxidant Vitamins, or the Combination for the Prevention of Coronary Disease

Bryan Brown, Xue-Qiao Zhao, Alan Chait et al. · New England Journal of Medicine · 2001 · 2K citations · Full text

Medicine, Cardiology, Pharmacotherapy +14

Effect of Recombinant ApoA-I Milano on Coronary Atherosclerosis in Patients With Acute Coronary Syndromes

Steven E. Nissen, Taro Tsunoda, E. Murat Tuzcu et al. · JAMA · 2003 · 1.7K citations · Full text

Medicine, Cardiology, Pharmacology +14

Effects of Lipid Lowering by Pravastatin on Progression and Regression of Coronary Artery Disease in Symptomatic Men With Normal to Moderately Elevated Serum Cholesterol Levels

J. Wouter Jukema, Albert V.G. Bruschke, Ad J. van Boven et al. · Circulation · 1995 · 844 citations

Medicine, Cardiology, Pharmacology +17